John Moore
Gynecology · Columbia, SCNPI 1851343040
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 31.3% of the total. Reporting peaked in 2019 at $663 and has fallen 58.3% since, to $277 in 2023.
Across 77 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$411
- Astellas Pharma US Inc$100
- Lupin Inc.$73
- Bayer$71
- Novo Nordisk$68
- Daiichi Sankyo Inc.$53
- plus $537 from 23 others
Across 135 payments — averaging $1618.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$193K
- Bayer$16K
- Pfizer$10K
What the payments were for
- Food & beverage$1,27597%
- Education$373%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 18 | $411 |
| Astellas Pharma US Inc | 6 | $100 |
| Lupin Inc. | 6 | $73 |
| Bayer | 5 | $71 |
| Novo Nordisk | 4 | $68 |
| Daiichi Sankyo Inc. | 3 | $53 |
| Pfizer | 3 | $52 |
| Amgen | 3 | $51 |
| Duchesnay USA Incorporated | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $39 |
| Therapeuticsmd, Inc. | 3 | $37 |
| AMAG Pharmaceuticals, Inc. | 3 | $37 |
| Mylan Pharmaceuticals Inc. | 2 | $33 |
| Meditrina | 1 | $29 |
| Shield Therapeutics Inc | 1 | $24 |
| Agile Therapeutics, Inc. | 1 | $21 |
| Exact Sciences | 1 | $16 |
| Exeltis, USA Inc. | 1 | $16 |
| Aspira Women's Health Inc | 1 | $15 |
| Millicent US Inc | 1 | $13 |
| Scynexis, Inc. | 1 | $13 |
| Gilead | 1 | $13 |
| Evofem Biosciences, Inc. | 1 | $13 |
| Coloplast | 1 | $12 |
| Coopersurgical, Inc. | 1 | $12 |
| Avion Pharmaceuticals | 1 | $12 |
| Hologic Sales And Service, LLC | 1 | $11 |
| Currax Pharmaceuticals LLC | 1 | $11 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$125
How this compares
$1,312 in reported general payments places this provider in the 65th percentile of 39 gynecology providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 43 | $2,147 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Columbia
- Albert OdomColumbia$26K
- Abigail SmithColumbia$2K
- Kathryn MooreColumbia$896
- Mary NeufferColumbia$333
- Francisco AguirreColumbia$127
- Jamie HamiltonColumbia$23
- Andrea PezzellaWest Columbia$99K
- Caroline FeltySimpsonville$7K
- Adrienne EllisSimpsonville$6K
- Claude TolbertBluffton$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.